Introduction
As is well known, mustard gas [bis (2-chloroethyl ethyl) sulfide], also known as sulfur mustard (HD), has long been known to be a vesicant in humans and, when inhaled, causes extreme lung damaging reactions (Eisenmenger et al., 1991; Khateri et al., 2003; Lakshmana Rao et al., 1999) . In human survivors, progressive lung dysfunction due to pulmonary fibrosis is well documented (Emad and Rezaian, 1999) . Not unexpectedly, HD is radiomimetic, teratogenic and mutagenic (Angelov et al., 1996; Dube et al., 1998) . Currently, there is no effective therapy for either the vesicant-inducing properties of HD or for the outcomes that can lead to acute and progressive lung injury and death.
2-Chloroethyl ethyl sulfide (CEES) is less toxic than HD and can be used in the absence of facilities required for HD studies. In rats CEES has been shown to induce acute lung injury in a dose-dependent and time-dependent manner (McClintock et al., 2002) . CEESinduced acute lung injury is complement-and neutrophildependent, suggesting that some of the CEES-induced injury is due to engagement of the inflammatory response in lung in an unknown manner (McClintock et al., 2002) . Furthermore, lung injury is attenuated after intravenous treatment with the anti-oxidant, N-acetylcysteine (NAC), or airway delivery of anti-oxidants or anti-oxidant enzymes (McClintock et al., 2002) . These data have suggested that CEES compromises the redox potential in the lung, putting it at risk of oxidant-mediated injury.
Liposomal delivery of drugs or chemical compounds is a way to achieve high tissue levels of a desired compound (Fan et al., 2000; Freeman et al., 1985; Suntres and Shek, 1996) . In the lung, airway delivery of liposomes results in macrophage uptake of liposomes by a phagocytic pathway (Gonzalez-Rothi et al., 1991; Shephard et al., 1981; Sone et al., 1980) . As far as is known, liposomes are not internalized by any other lung cells. The current studies demonstrated that liposomes containing anti-oxidants or anti-oxidant enzymes cause a reduction in acute lung injury in rats following airway delivery of CEES. Furthermore, delivery of such liposomes, when delayed 1 h after CEES administration, still provides significant attenuation of acute lung injury.
These findings may have important therapeutic implications for HD-induced acute lung injury in humans.
Materials and Methods

Chemicals
Except where noted, all chemicals and reagents were purchased from the Sigma Chemical Co. (St Louis, MO).
Animal Model
Adult male (275-325 g) specific pathogen-free LongEvans rats (Harlan Co., Indianapolis, IN) were used in these studies. Intraperitoneal ketamine (100 mg kg −1 body weight) (Fort Dodge Animal Health, Fort Dodge, IA) was used for anesthesia and intraperitoneal xylazine (13 mg kg −1 body weight) (Bayer Corp. Shawnee Mission, KS) was used for sedation when required (delayed time point liposome administration). The experimental procedure for CEES-induced lung injury in rats has been described previously (McClintock et al., 2002) . Briefly, after induction of anesthesia, 125 I-labeled bovine serum albumin ( 125 I-BSA, 0.5 µCi per rat) was injected intravenously as a quantitative marker for vascular leakage. The trachea was then surgically exposed and a slightly curved P50 catheter was inserted into the trachea past the bifurcation so as to facilitate a unilateral, left-lung injury. A small volume of CEES (2 µl per rat; about 6 mg kg −1 ) was solubilized in ethanol (58 µl per rat) and then added to a syringe containing Dulbecco's phosphate buffered saline (DPBS) (340 µl per rat). This solution was injected via the intratracheal catheter, into the left lung main stem bronchus. Studies, not requiring the usage of a radiolabeled marker, proceeded identically substituting DPBS for the radioactive injection. For all studies, except the time response experiment, animals were killed 4 h later, the pulmonary arterial circulation was flushed with 10 ml of cold DPBS, the lungs were surgically dissected, placed in counting vessels, and the amount of radioactivity ( 125 I-labeled BSA) determined by gamma counting. For calculations of the permeability index, the amount of radioactivity ( 125 I-labeled BSA) remaining in the lungs in which the vasculature was perfused with saline was divided by the amount of radioactivity present in 1.0 ml of blood obtained from the inferior vena cava at the time of killing as described elsewhere (McClintock et al., 2002) .
125 I-BSA present in the lung after thorough flushing of the vasculature is a quantitative measure of the degree of vascular endothelial and alveolar epithelial damage, in which much of the 125 I-BSA can be lavaged from the distal airway compartment, indicating the loss of the vascular and epithelial barriers (Johnson and Ward, 1974) .
All animal experiments were in accordance with the standards in The Guide for the Care and Use of Laboratory Animals, and were supervised by veterinarians from the Unit for Laboratory and Animal Care of the University of Michigan Medical School.
Complement Depletion
Cobra venom factor (CVF) was purified from crude, lyophilized cobra venom (Naja atra) by ion exchange chromatography (Ballow and Cochrane, 1969) . Complement depletion of experimental animals was achieved by intraperitoneal injections of 25 units of CVF per rat at time zero and 24 h later, resulting in undetectable levels of serum hemolytic complement activity as confirmed by CH50 assay (Mayer, 1961) . Experiments were performed 24 h after the second CVF injection.
Liposome Preparation
Dipalmitoylphosphatidylcholine (DPPC, Avanti Polar Lipids) was dissolved 20 mg ml −1 in a 2 : 1 v/v chloroform/methanol solution. When α-tocopherol (αT) was also included in the liposomes, it was added just after the chloroform/methanol solvent to provide a 7 : 3 molar ratio (DPCC : α-T) after first being carefully dissolved in a small volume of ethanol. The DPPC or (DPPC : α-T) solution was then dried under a thin stream of nitrogen in a round bottom flask to form a thin lipid film on the walls of the tube. Once the film had been dried, the tube was then placed on a vacuum for at least 1 h to further dry and remove any excess organic compounds from the lipid film.
The compounds being encapsulated in the liposomes were exclusively prepared in Dulbecco's phosphate buffered saline (DPBS), pH adjusted to 7.4 and then added to the lipid film. The tube was then vortexed to free the lipid film from the walls of the tube, and then placed in a heated water bath (41°C). When sizing the liposomes, it is necessary to keep them at a temperature above their transition phase. The transition phase temperature for DPPC is 41°C. Vortexing the liposomes once they are above the transition phase temperature results in large multilamellar vesicles. To reduce the size of the vesicles and to produce uniform small unilamellar vesicles, the lipid suspension was then passed ten times through polycarbonate membrane filters in a Liposofast Basic mini extruder available from Avestin, Inc. (Ottawa, Ontario). The resulting liposomes were uniform in size measuring 100 nm in diameter. According to the manufacturer, the use of an extruder is an efficient method for producing liposomes that are of relatively uniform size. Liposomes were checked via light microscopy for uniformity and size. Liposomes were injected intratracheally in a volume of 100 µl per rat through the same catheter setup used for CEES instillation at the time point designated by each individual experimental protocol.
Morphological Assessment of Lung Injury
In order morphologically to assess lung injury, lungs were fixed by intratracheal instillation of 10 ml buffered (pH 7.2) formalin (10%) at the indicated time points following airway instillation of CEES. Lung sections were then obtained for histological examination by staining with hematoxylin and eosin. In addition, lung sections were stained with trichrome in order to assess the deposition of fibrin and collagen (Luna, 1968) .
Statistical Analysis
The results are presented as mean ± SEM in the text and figures. Groups (n ≥ 5) were subjected to oneway analysis of variance and when significance was found, Student's t-test with the Bonferroni correction for multiple comparisons was applied. A value of P < 0.05 was considered significant.
Results
Histopathologic Features of Lung Response to CEES
Following airway instillation of CEES into rat lungs, tissues were obtained at 0, 6, 12 and 24 h as well 3 and 6 days and 6 weeks after exposure to CEES. Lung sections were stained with trichrome stain to evaluate lung deposition of fibrin and collagen. Composite results are shown in Fig. 1 (frames A-I) . At time 0, trichrome stains revealed the usual perivascular and septal evidence of collagen (frames A, B). As early as 6 h, increased evidence of trichrome stained deposition in alveolar walls was likely related to fibrin deposition (frame C). By 24 h after lung instillation of CEES, dense interstitial and intra-alveolar accumulations of trichrome positive (blue dye) were evident throughout the affected lungs, suggestive of increased deposition of fibrin and collagen fibers (frame D). Intra-alveolar hemorrhage, edema and intraalveolar accumulation of macrophages and mononuclear cells were found at 24 h (frame E). By 3 days, dense interstitial deposits of fibrin and collagen occurred (frame F). By day 6, extensive confluent collagen deposits were found in the lung, together with a collapse of alveolar structures and the appearance of honeycombing (frames G, H). By week 3, little recognizable lung structure remained in the face of dense collagen deposits and parenchymal collapse, together with numerous interstitial macrophages and mononuclear cells (frame I).
Attenuation of CEES-Induced Acute Lung Injury by Anti-Oxidant Enzymes in Liposomes
As shown in Fig. 2 , the airway instillation of CEES together with unloaded liposomes resulted 4 h later in approximately a 10-fold increase in lung injury, as defined by the leakage of 125 I-albumin from blood into the lung. When instilled into the lung immediately after CEES, polyethyleneglycol (PEG)-linked catalasecontaining liposomes (LIP-PEG-CAT) attenuated injury by 40%. Liposomes containing PEG-superoxide dismutase (PEG-SOD) diminished injury by 57%. The combination of PEG-SOD and PEG-CAT in liposomes further reduced injury by 71%. With the combination of PEG-SOD and PEG-CAT liposomes given to complement-depleted animals, the injury was reduced by 86%. These data indicate that anti-oxidant enzymes have powerful attenuative effects on CEES-induced acute lung injury. Since, as described above, airway delivery of liposomes results in their phagocytosis by lung macrophages, it seems likely that the attenuative effects of liposomes Fig. 1 . When used, liposomes were injected intratracheally immediately after the airway instillation of CEES. Lung injury was determined by the permeability index. αT, α-tocopherol containing anti-oxidant enzymes are due to the bolstering of anti-oxidant defenses in lung macrophages.
Attenuative Effects of Liposomes Containing Reducing Agents
In an additional set of experiments (shown in Fig. 3) , there was approximately a 10-fold increase in leakage of albumin from the circulation into the lungs of animals receiving airway instillation of CEES 4 h earlier together with unloaded liposomes. When liposomes containing NAC (Lip-NAC) were instilled immediately after CEES, injury was attenuated by 60%. Liposomes containing glutathione (GSH) led to a 48% reduction in lung injury. Liposomes containing α-tocopherol (αT) reduced injury by 37%. Liposomes containing the reducing agent present in red wine, resveratrol (RES), reduced injury by 48%, while liposomes containing PEG-CAT reduced injury by 44%. These data indicate that reducing agents presented in liposomes have significantly attenuative effects against CEES-induced acute lung injury. The data also indicate that the non-derivatized form of catalase (CAT) also has attenuative effects when given within liposomes.
Additive Effects of Complement Depletion and Liposomes Containing Reducing Agents
Previous studies in our laboratory have shown that complement depletion resulted in a 43% reduction of lung injury (McClintock et al., 2002) . As shown in Fig. 4 , approximately a 10-fold increase in the leakage of 125 I-albumin into the lungs occurred following instillation of CEES together with unloaded liposomes. When the animals were complement (C) depleted, the instillation Fig. 1 . Complement depletion was induced in four groups of animals by the prior intraperitoneal injection of purified cobra venom factor (CVF). Liposomes containing the various anti-oxidant compounds were given immediately after airway instillation of CEES. For each group, n ≥ 6 of liposomes containing NAC reduced injury by 79%, those containing GSH reduced injury by 72% in complement-depleted rats, liposomes containing the combination of NAC and GSH reduced injury by 78% in complement-depleted rats. Complement-depleted animals receiving liposomes containing αT together with GSH showed an 82% reduction in lung injury as measured by leakage of albumin from the blood. Thus, the combination of complement depletion and anti-oxidant liposomes seems significantly to attenuate CEES-induced acute lung injury in an additive manner.
Effects of Delayed Lung Instillation of Anti-Oxidant Liposomes
As shown in Fig. 5 , in CEES treated animals instillation of liposomes containing reducing agents was done either 10 min before the airway instillation of CEES or at 30, 60 and, in one case, 90 min following the airway instillation of CEES. As shown in Fig. 5 , over the course of the first 60 min after instillation of CEES, there were significant attenuative effects of liposomes containing NAC or GSH, or the combination. Under these circumstances, injury was reduced between 55% and 77%, respectively. In the case of liposomes containing the combination of NAC and GSH, even when delivery was delayed until 90 min following instillation of CEES, there was a 55% reduction in the development of acute lung injury. These data indicate that delayed airway administration of anti-oxidant-containing liposomes results in significant reduction of CEES-induced lung injury, even when delivery is delayed by at least an hour following exposure of lungs to CEES. 
Discussion
The data described in this report indicate that CEES instillation into the lung produces acute lung injury in a manner that seems related to the loss of the redox balance in the lung, although this has not been demonstrated directly. This conclusion is based on the attenuative effects of reducing agents (NAC, GSH, αT, resveratrol) or anti-oxidant enzymes (SOD, CAT) or various combinations, all presented in liposomes alone or in combination. Since it is well known that liposomes given into the airways are phagocytized by macrophages and internalized (Gonzalez-Rothi et al., 1991; Lentsch et al., 1999; Shephard et al., 1981) , the implications from the current studies are that liposomal delivery selectively enhances a reducing environment in lung macrophages, which may be compromised when these cells came into contact with CEES.
The morphological features described in this report are consistent with our earlier report of an accumulation of myeloperoxidase (MPO) in the lung after CEES instillation (McClintock et al., 2002) . The presence of alveolar hemorrhage and edema implies a severe disruption of vascular and distal airway barrier. These changes are consistent with the concept that CEES induces an acute lung-damaging inflammatory response that is complement-dependent. Beneficial effects of neutrophil and complement depletion as demonstrated previously indicate that the inflammatory response to CEES contributes to the development of lung injury (McClintock et al., 2002) . Masson's trichrome staining revealed an accumulation of fibrin and/or collagen within the alveolar spaces. Deposition of fibrin reflects a nonspecific reaction to tissue damage. It remains to be shown that CEES-exposure causes rapid development of interstitial fibrosis, as confirmed biochemically by collagen accumulation. It is hypothesized that epithelial and endothelial damage following CEES-exposure results in disruption of tissues, resulting in collagen accumulation in the interstitial and alveolar spaces. It appears likely that following lung exposure to CEES collagen deposition occurs in a widespread manner, resulting in parenchymal collapse and the honeycombing changes that occur in humans with pulmonary fibrosis. Numerous macrophages and mononuclear cells in areas of collagen deposition in the lung may be associated with the release of mediators (such as TGF β ) that promote lung production of collagen.
How CEES functions as a powerful oxidant and what lung cells are targets of CEES is unclear. The extensive leakage of albumin into the lung after exposure to airway administration of CEES infers that the blood-gas barrier has been seriously compromised, causing a functional impairment (or destruction) of both vascular endothelial and alveolar epithelial cells. The subsequent alveolar flooding with plasma components leaking into the distal airway compartment could seriously compromise bloodgas exchange, resulting in hypoxia.
The permeability index after instillation of CEES and empty liposomes was found to be similar to CEES instillation alone (as reported in McClintock et al., 2002) implying that empty liposomes do not cause any lung damage by themselves. The fact that the combination of complement depletion and liposomal delivery of GSH or NAC enhances the attenuation when compared with the use of either type of liposomes given to complementintact rats (Figs 3 and 4) suggests that it may be both the loss of reducing potential in the lung as well as an engagement of complement activation products (e.g. C5a) that leads to intense acute lung injury. Whether complement activation products are directly responsible for lung injury or are functioning to enhance cytokine and chemokine expression remains to be determined. In a recent study it was shown that neutrophil depletion prior to CEES delivery was also capable of reducing CEESinduced lung injury (McClintock et al., 2002) , suggesting that activated neutrophils enter into the sequence of destructive events after CEES instillation into the lung.
A matter of considerable interest is that delayed delivery (for as long as 60 min) of liposomes containing NAC or GSH, or the combination, into lungs after CEES instillation still provides substantial attenuation from the massive leak of albumin into the lung. It should be noted that there is not much increased albumin leak into the lung in the first 60 min after administration of CEES (McClintock et al., 2002) . In fact, compared with values at 1 h, the permeability index at 2, 4 and 6 h after instillation of CEES rose 2 fold, 2.9 fold, 7.7 fold and 16.2 fold, respectively, when compared with uninjured lung values. Accordingly, the development of extensive lung injury after airway instillation of CEES requires considerable time for full development of lung injury. This would be in accord with the concept that CEES triggers in the lung an acute inflammatory response, which itself serves to cause lung damage. Since this sequence requires several hours before the large increases in lung permeability (albumin leak into lung) are seen, this may explain why delayed administration of anti-oxidant liposomes can still bring about significant attenuative effects. Understanding more fully the molecular events that lead to CEES-induced intense acute lung injury may provide even better strategies for effective therapeutic intervention after exposure of lung to HD and related compounds.
